The Sixth European Society of Pharmacogenomics and Personalised Therapy Congress-Reference-Cited by-同舟云学术

The Sixth European Society of Pharmacogenomics and Personalised Therapy Congress

Published:2023-04 Issue:5 Volume:24 Page:243-246
ISSN:1462-2416
Container-title:Pharmacogenomics
language:en
Short-container-title:Pharmacogenomics

Author:

van Schaik Ron HN¹^ORCID,Manolopoulos Vangelis G²,Daly Ann K³,Niemi Mikko⁴,Zukic Branka⁵,Patrinos George P⁶⁷⁸,Primorac Dragan⁹,Swen Jesse J¹⁰^ORCID,Ingelman-Sundberg Magnus¹¹,Morris Tiffany¹²,Molden Espen¹³,Müller Daniel¹⁴,Pavlovic Sonja⁵,Russmann Stefan¹⁵,Ansari Marc¹⁶,Henricks Linda M¹⁷,den Broek Wout van¹⁸,Florindi Francesco¹⁹,Bozina Nada²⁰,Akin Demet²¹,Christrup Lona²²,Llerena Adrian²³^ORCID,Sipeky Cilla²⁴,Stankovic Sanja²⁵

Affiliation:

1. Department of Clinical Chemistry, Erasmus MC-University Medical Center, Rotterdam, The Netherlands

2. Department of Pharmacology, Democritus University of Thrace, Alexandroupolis, Greece

3. Translational & Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK

4. Department of Clinical Pharmacology, University of Helsinki, Helsinki, Finland

5. Institute of Molecular Genetics & Genetic Engineering, University of Belgrade, Belgrade, Serbia

6. Laboratory of Pharmacogenomics & Individualised Therapy, University of Patras, Department of Pharmacy, Patras, Greece

7. Department of Genetics & Genomics, United Arab Emirates University, College of Medicine & Health Sciences, Al Ain, Abu Dhabi, UAE

8. Zayed Center for Health Sciences, United Arab Emirates University, Al Ain, Abu Dhabi, UAE

9. St. Catherine Specialty Hospital, Zagreb, Croatia

10. Department of Clinical Pharmacology & Toxicology, Leiden University Medical Center, Leiden, The Netherlands

11. Department of Physiology & Pharmacology, Karolinska Institutet, Stockholm, Sweden

12. Precision Health & Pharmacogenomics, Illumina, Cambridge, UK

13. Department of Pharmacy, University of Oslo, Oslo, Norway

14. Department of Psychiatry, University of Toronto, Toronto, Canada

15. ETH Zürich, Hirslanden Hospitals & drugsafety.ch, Switzerland

16. Cansearch Research Platform for Pediatric Oncology & Hematology, Faculty of Medicine, Department of Pediatrics, Gynecology & Obstetrics, University of Geneva, Switzerland

17. Division of Pediatric Oncology & Hematology, Department of Women, Child & Adolescent, University Geneva Hospitals, Geneva, Switzerland

18. Department of Clinical Chemistry, Leiden University Medical Center, Leiden, The Netherlands

19. Strategy & Partnership, Thermo Fisher Scientific, Brussels, Belgium

20. Department of Pharmacology, University of Zagreb, Zagreb, Croatia

21. Department of Pharmacology, Bahcesehir University, Istanbul, Turkey

22. Department of Drug Design & Pharmacology, University of Copenhagen, Copenhagen, Denmark

23. INUBE Biosanitary University Research Institute, University of Extramedura, Spain

24. Department of Translational Medicine, UCB Biopharma, Waterloo, Belgium

25. Department of Medical Biochemistry, University Clinical Center of Serbia, Belgrade, Serbia

Abstract

On 8–9 November 2022, the European Society of Pharmacogenomics and Personalised Therapy organized its sixth biennial congress, in Belgrade, Serbia (congress website: www.sspt.rs ). The congress aimed to address the current status and future perspectives of pharmacogenomics, share latest knowledge in the field of precision medicine and showcase the implementation of clinical applications in pharmacogenomics/pharmacogenetics. The 2 day congress consisted of 17 lectures given by key-opinion leaders and included a poster session plus discussions. The meeting was a great success by generating an informal environment and enabling the exchange of information between 162 participants from 16 different countries.

Publisher

Future Medicine Ltd

Subject

Pharmacology,Genetics,Molecular Medicine

Link

https://www.futuremedicine.com/doi/pdf/10.2217/pgs-2023-0013

Reference19 articles.

1. Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-Clavulanate

2. Polygenic architecture informs potential vulnerability to drug-induced liver injury

3. Application of Economic Evaluation to Assess Feasibility for Reimbursement of Genomic Testing as Part of Personalized Medicine Interventions

4. ePGA: A Web-Based Information System for Translational Pharmacogenomics

5. Pharmacogenomics at the center of precision medicine: challenges and perspective in an era of Big Data

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding how big data awareness affects healthcare institution performance in Oman;Artificial Intelligence, Big Data, Blockchain and 5G for the Digital Transformation of the Healthcare Industry;2024

2. Population Pharmacogenomics in Croatia: Evaluating the PGx Allele Frequency and the Impact of Treatment Efficiency;International Journal of Molecular Sciences;2023-08-31